Name: SABS Balance Sheet - Sab Biotherapeutics Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

SABS - Sab Biotherapeutics, Inc.

USD | NASDAQ | Healthcare

SABS Balance Sheet - Sab Biotherapeutics Assets & Debt | Ledgeburg

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q4 FY 19
Cash And Short Term Investments
Cash And Equivalents	20.5	10.5	29.4	3.7	5.6	8.9	9.2	17.2	14.0	56.6	2.4	7.8	13.1	15.0	8.3

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Cash And Short Term Investments
Cash And Equivalents	10.5	8.9	56.6	15.0	33.2	12.6	-
Restricted Cash	-	-	-	0.0	6.3	0.0	-
Short Term Investments	86.1	11.9	0.0	-	-	-	-
Cash And Short Term Investments	96.6	20.8	56.6	15.0	33.2	12.6	-
Receivables
Accounts Receivable	-	-	0.0	5.6	8.0	20.6	-
Current Assets
Inventory	-	-	-	-	-	-	-
Prepaid Expenses	3.5	3.0	2.3	1.5	2.6	1.3	-
Non-Current Assets
Property, Plant & Equipment Gross	30.8	29.9	29.6	29.5	-	-	-
Accumulated Depreciation	17.5	14.6	9.9	6.3	3.2	1.8
Current Liabilities
Accounts Payable	3.1	1.7	0.9	3.7	4.5	7.4	-
Short Term Debt	-	-	-	-	-	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	1.9	0.6	0.6	0.4	1.7	2.4
Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	-
Additional Paid In Capital	267.7	155.8	152.9	84.4	67.7	51.0
Supplementary Data
Total Debt	-	-	-	-	-	-	-
Net debt	-	-	-	-	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	3.8	3.5	1.8	3.6	3.4	3.0	2.0	2.0	2.7	2.3	0.7	0.9	1.2	1.5	0.9	0.9	0.1	0.2
Other Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	112.8	101.1	113.3	9.3	16.3	23.8	32.5	39.6	47.0	58.9	3.1	9.0	15.0	22.1	22.2	48.4

Non-Current Assets
Property, Plant & Equipment Gross	31.9	30.8	29.9	29.9	29.9	29.9	29.9	29.8	29.8	29.6	29.6	29.6	29.6	29.5	29.4	27.5	-	-	-	-	-
Accumulated Depreciation	18.1	17.5	16.8	16.1	15.3	14.6	13.8	12.9	11.9	9.9	9.0	8.1	7.2	6.3	5.4	3.2	-
Property,Plant & Equipment Net	13.8	13.3	13.1	13.9	14.6	15.4	16.1	16.9	17.9	19.7	20.6	21.5	22.4	23.3	24.0	24.3
Long Term Investments	110.2	46.9	50.6	-	-	-	-	-	1.2	0.0	-	-	-	-	-	-	-
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Right Of Use Assets	2.9	2.6	2.8	3.0	3.2	1.0	1.1	1.2	1.1	1.3	0.5	0.7	1.0	1.2	1.9	2.6
Deferred Tax Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	248.5	172.8	183.4	30.1	38.1	44.2	53.8	61.9	71.4	83.9	28.3	35.4	42.7	50.9	52.5	79.4	116.9

Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	2.2	1.9	2.0	2.3	2.5	0.6	0.7	0.8	0.6	0.6	0.0	0.1	0.2	0.4	0.8	1.7
Deferred Revenue Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	21.2	21.3	18.4	18.1	16.7	18.2	16.9	15.8	18.5	26.6	13.1	15.7	18.3	19.8	21.9	40.8

Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-
Additional Paid In Capital	362.7	267.7	264.6	157.0	156.4	155.8	155.1	154.1	153.5	152.9	88.0	87.3	85.1	84.4	76.1	67.7	-
Retained Earnings	(129.8)	(110.9)	(94.0)	(139.5)	(129.4)	(124.2)	(112.8)	(102.4)	(95.1)	(90.1)	(67.2)	(62.1)	(55.2)	(47.9)	(40.0)	(29.1)	(9.3)
Accumulated Other Comprehensive Income	(0.2)	0.2	0.1	(0.0)	(0.1)	(0.1)	0.1	(0.0)	(0.1)	0.0	-	-	-	-	-	-
Treasury Stock	5.5	5.5	5.5	5.5	5.5	5.5	5.5	5.5	5.5	5.5	5.5	5.5	5.5	5.5	5.5	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	227.2	151.5	165.1	12.0	21.4	26.0	36.9	46.1	52.8	57.3	15.3	19.7	24.4	31.1	30.6	38.5	35.1
Total Equity	227.2	151.5	165.1	12.0	21.4	26.0	36.9	46.1	52.8	57.3	15.3	19.7	24.4	31.1	30.6	38.5	35.1	38.3

Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Working Capital	102.9	90.4	102.5	(1.4)	6.6	15.8	23.7	32.0	38.6	48.1	(6.1)	(2.0)	1.4	7.1	5.1	23.7	0.4	0.8
Book Value	227.2	151.5	165.1	12.0	21.4	26.0	36.9	46.1	52.8	57.3	15.3	19.7	24.4	31.1	30.6	38.5	35.1	38.3
Tangible Book Value	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-